MarketBeat published a buy rating and target price increase for a company, with disclosures made under a Rule 10b5-1 trading plan.
2 reports, 1 independent
Updated Sep 13
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat published a buy rating and target price increase for a company, with disclosures made under a Rule 10b5-1 trading plan.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.MarketBeat rated Cineverse; Benchmark raised target; insider sale disclosed to SEC.1 source
Analyst rating upgrade and price target increase disclosed under Rule 10b5-1 trading plan.1 source
Keep exploring
The entities involved
-
SEC
Slovak company
-
MarketBeat
American personal finance blog
-
Cineverse
American entertainment company
Nothing else this week.
-
Benchmark
venture capital firm
Related events
- MarketBeat provided average ratings and target prices, while Jefferies Financial Group began coverage with a buy rating for Crane NXT.
- MarketBeat provided consensus ratings and target prices regarding Duke Capital Limited on August 12, 2026.
- Needham & Company raised its price objective and issued a buy rating for Ceragon Networks, with MarketBeat reporting consensus data.
- MarketBeat reported average rating data as Barclays raised its price target and TD Cowen raised its price target for Brinker International.
- MarketBeat is aggregating consensus ratings for Cytokinetics, while Bank of America provided a neutral rating and Morgan Stanley raised its target price.